Scroll News
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
  • Tech
    • App News
    • Gadgets
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Finance/Money
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
  • Tech
    • App News
    • Gadgets
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Finance/Money
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
Scroll News
No Result
View All Result
Home Lifestyle Health & Fitness

First mRNA-based COVID 19 vaccine gets nod for phase II/III trial

Scroll News by Scroll News
August 25, 2021
in Health & Fitness, National
0
Share on FacebookShare on Twitter

New Delhi: The fight against the ongoing epidemic of COVID-19 is all set to get stronger. The office of the Drug Controller General of India has approved a proposal of the Pune-based Gennova Biopharmaceuticals Ltd., to go in for phase II / III trial of the country’s first mRNA-based vaccine for COVID-19 called HGCO19.

The company had submitted the interim clinical data of the Phase I study to the Central Drugs Standard Control Organisation (CDSCO), the Government of India’s National Regulatory Authority (NRA). The Vaccine Subject Expert Committee (SEC) reviewed the data and found that the vaccine was safe, tolerable, and immunogenic in the participants of the study.

You May Also Like This

India’s Dengue Hotspots: PharmEasy Report Shows Karnataka, Tamil Nadu, and Maharashtra Leading the Charts

India’s Dengue Hotspots: PharmEasy Report Shows Karnataka, Tamil Nadu, and Maharashtra Leading the Charts

August 29, 2025
Kalmykia Delegation Arrived  in India, Boosting Cultural and Spiritual Cooperation

Kalmykia Delegation Arrived  in India, Boosting Cultural and Spiritual Cooperation

August 28, 2025
Redefining Fitness In India: Siraj Lalani’s Vision With Plus Fitness 

Redefining Fitness In India: Siraj Lalani’s Vision With Plus Fitness 

August 13, 2025

Consequently, the proposal for Phase II and Phase III study for “A prospective, multicentre, randomized, active-controlled, observer-blind, phase II study seamlessly followed by a phase III study to evaluate the safety, tolerability, and immunogenicity of the candidate HGCO19 (covid-19 vaccine) in healthy subjects” was submitted that has now been approved.

The study will be conducted within India in 10-15 sites in Phase II and 22-27 sites in Phase III. Gennova plans to use the DBT-ICMR clinical trial network sites for this study.

The vaccine development program was partly funded by the Department of Biotechnology (DBT), Govt. of India under Ind CEPI, in June 2020. Later on, the DBT further supported the program under the Mission COVID Suraksha – The Indian COVID-19 Vaccine Development Mission, implemented by BIRAC.

“It is a matter of great pride that Nation’s first mRNA-based vaccine is found to be safe and the Drugs Controller General of India DCG(I) has approved Phase II/III trial. We are confident that this will be an important vaccine for both India and the world. This is an important milestone in our Indigenous Vaccine Development Mission and positions India on the Global Map for Novel Vaccine Development,” said Dr.RenuSwarup, Secretary, DBT, and Chairperson, Biotechnology Industry Research Assistance Council (BIRAC).

Dr. Sanjay Singh, CEO of Gennova Biopharmaceuticals Ltd., said that “After establishing the safety of our mRNA-based COVID-19 vaccine candidate HGCO19 in Phase I clinical trial, Gennova’s focus is to start Phase II/III pivotal clinical trial. In parallel, Gennova is investing in scaling up its manufacturing capacity to cater to the nation’s vaccine requirement”. (India Science Wire)

Tags: CDSCOCentral Drugs Standard Control OrganisationCOVID SurakshaDBTDCG (I)Department of BiotechnologyDrug Controller General of IndiaGennova Biopharmaceuticals Ltd.immunogenicityInd CEPImRNAPunesafetytolerabilityvaccine
ShareTweetShareShareSendSend
Previous Post

Ogo Nirupama actress Arkoja Acharyya celebrates Rakshabandhan with renowned singer and producer Sarbajit Ghosh through upcoming calendar photoshoot

Next Post

Government incentive in offing for 75 start-ups in telemedicine, artificial intelligence, and digital health

Related Posts

India’s Dengue Hotspots: PharmEasy Report Shows Karnataka, Tamil Nadu, and Maharashtra Leading the Charts
Health & Fitness

India’s Dengue Hotspots: PharmEasy Report Shows Karnataka, Tamil Nadu, and Maharashtra Leading the Charts

August 29, 2025
Kalmykia Delegation Arrived  in India, Boosting Cultural and Spiritual Cooperation
National

Kalmykia Delegation Arrived  in India, Boosting Cultural and Spiritual Cooperation

August 28, 2025
Redefining Fitness In India: Siraj Lalani’s Vision With Plus Fitness 
Health & Fitness

Redefining Fitness In India: Siraj Lalani’s Vision With Plus Fitness 

August 13, 2025
Robotic-Assisted Breast Surgery: A New Era in Cancer Care- Dr. Sandeep Nayak
Health & Fitness

Robotic-Assisted Breast Surgery: A New Era in Cancer Care- Dr. Sandeep Nayak

July 31, 2025
The Science of Thicker Hair: Why Combining Bio-FUE with GFC Is Redefining Hair Restoration
Health & Fitness

The Science of Thicker Hair: Why Combining Bio-FUE with GFC Is Redefining Hair Restoration

July 24, 2025
Breathe Easy This Monsoon: Pravek Kalp’s Ayurvedic ‘Cough Kalp’ Offers Natural Relief
Health & Fitness

Breathe Easy This Monsoon: Pravek Kalp’s Ayurvedic ‘Cough Kalp’ Offers Natural Relief

July 23, 2025
Next Post

Government incentive in offing for 75 start-ups in telemedicine, artificial intelligence, and digital health

Niti Vakharia Kharwar from Nits saloon was honoured by One Step Charitable Trust as “Real Heroes of Surat”

"When you dream big, you got to work just as hard." says Pardeep Singh Toor

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Doceree Is Now Great Place To Work Certified

Doceree Is Now Great Place To Work Certified

2 years ago

Japan’s tech start-ups bitgrit and Atrae rolls out professional ‘matching’ app in India offering jobs in India

5 years ago

StayHappi Pharmacy conducts Free Medical Health Camp at Pitampura New Delhi

4 years ago
Aida Travels: Making UAE Feel Like Home for You and Your Family

Aida Travels: Making UAE Feel Like Home for You and Your Family

6 months ago

Categories

  • Agriculture
  • App News
  • Astrology
  • Auto
  • Business
  • Education
  • Entertainment
  • Fashion & Beauty
  • Finance/Money
  • Food
  • Gadgets
  • Health & Fitness
  • Lifestyle
  • National
  • Photography
  • Politics
  • Press Release
  • Religion
  • Science
  • Social Work
  • Sports
  • State News
  • Tech
  • Travel
  • World

Topics

Ace Entrepreneur actor Artificial intelligence Bangalore Bengaluru Blockchain technology BRICS CCI Content Creator COVID-19 Cryptocurrency CSIR DBT Delhi Digital Marketing digital marketing agency DST Dubai Education entrepreneur entrepreneurship Fairplay Gujarat Gurugram Hyderabad IIT Delhi India Indian Institute of Technology Influencer Influencerquipo innovation Kingston Technology K Raheja Corp Homes memory products and technology solutions Mumbai Music Industry pandemic photography producer Pune real estate research Shan Se Entertainment Shantanu Bhamare social media Surat
No Result
View All Result

Highlights

Onlive Server Rolls Out Premium 10 Gbps France Dedicated Server Plans with No Setup Fees

Over 500 Participate in Wheelchair Sports & Cultural Program & Inclusive Health Checkup camp at NCDC for Spinal Cord Injury Day & National Injury Prevention Week 2025

JD Institute of Fashion Technology and JD School of Design Launch Future-Ready Digital Design Experience Programs in Bengaluru

India’s Dengue Hotspots: PharmEasy Report Shows Karnataka, Tamil Nadu, and Maharashtra Leading the Charts

Visionnaire introduces its Neolito Bedroom

Stop Collecting, Start Connecting: Helo.ai’s Prashant Gadekar Unveils Future of CX at IAMAI CLICK Summit

Trending

Breaking the Monotony: How NoMoreType is Redefining Digital Lifestyle Shopping
Lifestyle

Breaking the Monotony: How NoMoreType is Redefining Digital Lifestyle Shopping

by Scroll News
September 8, 2025
0

The global lifestyle e-commerce market, valued at $368 billion in 2024, faces a curious problem. Despite endless...

From Flood Ruins to Global Recognition: Vilvex Cables’ Remarkable CE Marking Achievement

From Flood Ruins to Global Recognition: Vilvex Cables’ Remarkable CE Marking Achievement

September 5, 2025
India’s First Nanobubble Pioneer: How Prasinos Made World-Class Technology Affordable for Everyone

India’s First Nanobubble Pioneer: How Prasinos Made World-Class Technology Affordable for Everyone

September 5, 2025
Onlive Server Rolls Out Premium 10 Gbps France Dedicated Server Plans with No Setup Fees

Onlive Server Rolls Out Premium 10 Gbps France Dedicated Server Plans with No Setup Fees

September 5, 2025
Over 500 Participate in Wheelchair Sports & Cultural Program & Inclusive Health Checkup camp at NCDC for Spinal Cord Injury Day & National Injury Prevention Week 2025

Over 500 Participate in Wheelchair Sports & Cultural Program & Inclusive Health Checkup camp at NCDC for Spinal Cord Injury Day & National Injury Prevention Week 2025

September 1, 2025
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News

© 2022 Scroll News

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

© 2022 Scroll News